Pregnancy rates to timed artificial insemination in Holstein heifers given prostaglandin F2alpha twenty-four hours before or concurrent with removal of an intravaginal progesterone-releasing insert.
The objective was to compare pregnancy rates in nulliparous Holstein heifers given PGF(2alpha) 24 h before, or concurrent with, removal of an intravaginal progesterone-releasing (CIDR) insert in 3 timed artificial insemination (TAI) protocols. Heifers (from 2 herds) were assigned randomly, over 11 mo, to 1 of 3 modified Ovsynch protocols. On d 0 (without reference to the stage of the estrous cycle), all heifers were given 100 microg of GnRH i.m. and a CIDR insert (containing 1.9 g of progesterone). In the PG-7/P4-8 protocol (n = 99), PGF(2alpha) was given on d 7, and CIDR inserts were removed on d 8. In the PG-7/P4-7 (n = 98) and PG-8/P4-8 (n = 102) protocols, PGF(2alpha) administration and CIDR removal occurred concurrently, on d 7 or 8, respectively. In all 3 protocols, a second GnRH treatment (100 microg) was given 48 h after PGF(2alpha) with TAI 16 to 20 h later. Blood samples were collected (subset of 124 heifers) on d 0, 7, 10 or 11 (i.e., at TAI), and 17. Pregnancy rates (32 d after TAI) for protocols PG-7/P4-8, PG-7/P4-7, and PG-8/P4-8 were 61.8, 55.6, and 54.1%, respectively. Pregnancy rate was higher when synchronization was initiated during diestrus than when initiated at other stages (57.0 versus 34.8%). Although pregnancy rates were not affected by season, there was an interaction between protocol and season; pregnancy rates were significantly lower in summer in heifers subjected to PG-7/P4-7 and PG-8/P4-8, but season did not affect pregnancy rates in heifers subjected to PG-7/P4-8. In summary, giving PGF(2alpha) 24 h before CIDR removal, followed by TAI (PG-7/P4-8 protocol), resulted in consistent pregnancy rates, regardless of season, relative to protocols involving PGF(2alpha) treatment concurrent with CIDR removal.
Ambrose
D J
DJ
Dairy Research and Technology Centre, Alberta Agriculture and Rural Development, Edmonton, Alberta, Canada T6H 5T6. divakar.ambrose@gov.ab.ca
Emmanuel
D G V
DG
Colazo
M G
MG
Kastelic
J P
JP
D000282:Administration, Intravaginal; D000818:Animals; D002417:Cattle / Q000502:physiology*; D015237:Dinoprost / Q000008:administration & dosage*; D030762:Estrous Cycle / Q000502:physiology; D004973:Estrus Synchronization; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage; D007273:Injections, Intramuscular; D007315:Insemination, Artificial / Q000662:veterinary; D010062:Ovulation Induction / Q000379:methods / Q000662:veterinary; D011247:Pregnancy; D018873:Pregnancy Rate; D011374:Progesterone / Q000008:administration & dosage*; D012621:Seasons; D013997:Time Factors
D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D015237:Dinoprost